Development of a new smart theranostic anti-PSMA-aptamer conjugated cationic-lipid coated mesoporous silica platform for targeted delivery of paclitaxel and CdSe/ZnS quantum dots to LNCaP cell line-Reference-Cited by-同舟云学术

Development of a new smart theranostic anti-PSMA-aptamer conjugated cationic-lipid coated mesoporous silica platform for targeted delivery of paclitaxel and CdSe/ZnS quantum dots to LNCaP cell line

Published:2023-10 Issue: Volume:88 Page:104964
ISSN:1773-2247
Container-title:Journal of Drug Delivery Science and Technology
language:en
Short-container-title:Journal of Drug Delivery Science and Technology

Author:

Saharkhiz Shaghayegh,Nasri Negar^ORCID,Dini Ghasem^ORCID,Yousefnia Saghar^ORCID

Funder

University of Isfahan

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference54 articles.

1. Cancer statistics, 2023;Siegel;CA A Cancer J. Clin.,2023

2. Epidemiology of prostate cancer;Rawla;World J. Oncol.,2019

3. Novel therapies are changing treatment paradigms in metastatic prostate cancer;Powers;J. Hematol. Oncol.,2020

4. Taxanes in the management of metastatic castration-resistant prostate cancer: efficacy and management of toxicity;Schutz;Crit. Rev. Oncol. Hematol.,2014

5. A review of research progress of antitumor drugs based on tubulin targets;Cheng;Transl. Cancer Res.,2020

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A comprehensive review on lncRNA LOXL1-AS1: molecular mechanistic pathways of lncRNA LOXL1-AS1 in tumorigenicity of cancer cells;Frontiers in Oncology;2024-07-29

2. Evaluating a targeted Palbociclib-Trastuzumab loaded smart niosome platform for treating HER2 positive breast cancer cells;International Journal of Pharmaceutics: X;2024-06

3. Cutting-edge advancements in anticancer drug delivery and scope for theranostics using biocompatible multifunctional mesoporous silica nanoparticles;Journal of Drug Delivery Science and Technology;2024-04

4. Development of pH and thermo-responsive smart niosomal carriers for delivery of gemcitabine to the breast cancer cells;Emergent Materials;2024-03-15

5. Emerging Trends of Nanomedicines in the Management of Prostate Cancer: Perspectives and Potential Applications;Pharmaceutics;2024-02-20